173 related articles for article (PubMed ID: 31135703)
1. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).
Hsieh MS; How CK; Hsieh VC; Chen PC
Shock; 2020 Apr; 53(4):407-415. PubMed ID: 31135703
[TBL] [Abstract][Full Text] [Related]
2. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
Doege C; Luedde M; Kostev K
JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.
Morales DR; Conover MM; You SC; Pratt N; Kostka K; Duarte-Salles T; Fernández-Bertolín S; Aragón M; DuVall SL; Lynch K; Falconer T; van Bochove K; Sung C; Matheny ME; Lambert CG; Nyberg F; Alshammari TM; Williams AE; Park RW; Weaver J; Sena AG; Schuemie MJ; Rijnbeek PR; Williams RD; Lane JCE; Prats-Uribe A; Zhang L; Areia C; Krumholz HM; Prieto-Alhambra D; Ryan PB; Hripcsak G; Suchard MA
Lancet Digit Health; 2021 Feb; 3(2):e98-e114. PubMed ID: 33342753
[TBL] [Abstract][Full Text] [Related]
4. New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
King JB; Berchie RO; Derington CG; Marcum ZA; Scharfstein DO; Greene TH; Herrick JS; Jacobs JA; Zheutlin AR; Bress AP; Cohen JB
J Am Heart Assoc; 2023 Sep; 12(17):e030311. PubMed ID: 37646208
[TBL] [Abstract][Full Text] [Related]
5. Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study.
Choi J; Lee SR; Choi EK; Lee KY; Ahn HJ; Kwon S; Kim B; Han KD; Oh S; Lip GYH
Front Cardiovasc Med; 2024; 11():1372505. PubMed ID: 38784173
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study.
Ho CM; Lee CH; Lee MC; Zhang JF; Wang JY; Hu RH; Lee PH
BMC Cancer; 2018 Apr; 18(1):401. PubMed ID: 29631561
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
Ren L; Yu S; Xu W; Overton JL; Chiamvimonvat N; Thai PN
J Cardiol; 2021 May; 77(5):482-491. PubMed ID: 33168337
[TBL] [Abstract][Full Text] [Related]
9. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
Hiroi S; Shimasaki Y; Kikuchi T; Otsuka Y; Iwasaki K; Ohishi M
Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
[TBL] [Abstract][Full Text] [Related]
10. Comparing Outcomes Between Thiazide Diuretics and Other First-line Antihypertensive Drugs in Long-term Nursing Home Residents.
Boockvar KS; Song W; Lee S; Intrator O
Clin Ther; 2020 Apr; 42(4):583-591. PubMed ID: 32229030
[TBL] [Abstract][Full Text] [Related]
11. Enteropathy and intestinal malabsorption in patients treated with antihypertensive drugs.
Lee SR; Lee EG; Cho YH; Park EJ; Lee YI; Choi JI; Kwon RJ; Son SM; Lee SY; Yi YH; Kim GL; Kim YJ; Lee JG; Tak YJ; Lee SH; Ra YJ
Saudi Med J; 2024 Apr; 45(4):437-441. PubMed ID: 38657980
[TBL] [Abstract][Full Text] [Related]
12. Prior Use of Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and Clinical Outcomes of Sepsis and Septic Shock: A Systematic Review and Meta-analysis.
Shrestha DB; Sedhai YR; Oli PR; Proskuriakova E; Adelkhanova A; Shtembari J; Khan TMA; Singh K; Ahmed MA; Waheed I; Kazimuddin N; Steff R; Acharya R; Patel NK
J Cardiovasc Pharmacol; 2024 Jan; 83(1):16-22. PubMed ID: 37815234
[TBL] [Abstract][Full Text] [Related]
13. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.
Huang SH; Hsu CN; Yu SH; Cham TM
BMC Public Health; 2012 May; 12():288. PubMed ID: 22521158
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.
Rezel-Potts E; Douiri A; Chowienczyk PJ; Gulliford MC
Br J Clin Pharmacol; 2021 Dec; 87(12):4598-4607. PubMed ID: 33908074
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensives and their relation to mortality by SARS-CoV-2 infection.
Singh S; Widrich C; Nap M; Schokker E; Zwinderman AH; Pinto-Sietsma SJ
J Med Virol; 2021 Apr; 93(4):2467-2475. PubMed ID: 33404127
[TBL] [Abstract][Full Text] [Related]
16. Relationship between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prescribing and delirium in the ICU-A secondary analysis.
Mulkey MA; Khan S; Perkins A; Gao S; Wang S; Campbell N; Khan B
J Am Geriatr Soc; 2023 Jun; 71(6):1873-1880. PubMed ID: 36905601
[TBL] [Abstract][Full Text] [Related]
17. Effect of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on In-Hospital Outcomes Based on Renal Function Among Critically Ill Patients: Findings From the Medical Information Mart for Intensive Care IV Database.
Zhang C; Hou TH; Wang F; Hao CJ; Ning M; Shen HC; Chen Y; Liu YW
J Clin Pharmacol; 2023 Dec; 63(12):1344-1351. PubMed ID: 37408508
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin-converting enzyme inhibitors
Kang SH; Kim GO; Kim BY; Son EJ; Do JY
Ren Fail; 2024 Dec; 46(1):2313173. PubMed ID: 38522955
[TBL] [Abstract][Full Text] [Related]
19. Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study.
Nielsen SK; Lamberts M; Nouhravesh N; Jensen MH; Strange JE; Gislason G; Mcgettigan P; Holt A
Int J Cardiol; 2024 Aug; 408():132137. PubMed ID: 38705205
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor blockade is associated with increased risk of giant cell arteritis.
Zhao SS; Lyu H; Zeng C; Lei G; Wei J; Mackie SL
Rheumatology (Oxford); 2023 Jun; 62(6):2203-2210. PubMed ID: 36255257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
